Impact of fan therapy during exercise on breathlessness and recovery time in patients with COPD: a pilot randomised controlled crossover trial

Alex Long, Martin Cartwright, Charles C Reilly, Alex Long, Martin Cartwright, Charles C Reilly

Abstract

Background: Patients with COPD reduce physical activity to avoid the onset of breathlessness. Fan therapy can reduce breathlessness at rest, but the efficacy of fan therapy during exercise remains unknown in this population. The aim of the present study was to investigate 1) the effect of fan therapy on exercise-induced breathlessness and post-exercise recovery time in patients with COPD and 2) the acceptability of fan therapy during exercise; and 3) to assess the reproducibility of any observed improvements in outcome measures.

Methods: A pilot single-centre, randomised, controlled, crossover open (nonmasked) trial (clinicaltrials.gov NCT03137524) of fan therapy versus no fan therapy during 6-min walk test (6MWT) in patients with COPD and a modified Medical Research Council (mMRC) dyspnoea score ≥2. Breathlessness intensity was quantified before and on termination of the 6MWT, using the numerical rating scale (NRS) (0-10). Post-exertional recovery time was measured, defined as the time taken to return to baseline NRS breathlessness score. Oxygen saturation and heart rate were measure pre- and post-6MWT.

Results: 14 patients with COPD completed the trial per protocol (four male, 10 female; median (interquartile range (IQR)) age 66.50 (60.75 to 73.50) years); mMRC dyspnoea 3 (2 to 3)). Fan therapy resulted in lower exercise-induced breathlessness (ΔNRS; Δ modified Borg scale) (within-individual differences in medians (WIDiM) -1.00, IQR -2.00 to -0.50; p<0.01; WIDiM -0.25, IQR -2.00 to 0.00; p=0.02), greater distance walked (metres) during the 6MWT (WIDiM 21.25, IQR 12.75 to 31.88; p<0.01), and improved post-exertional breathlessness (NRS) recovery time (WIDiM -10.00, IQR -78.75 to 50.00; p<0.01). Fan therapy was deemed to be acceptable by 92% of participants.

Conclusion: Fan therapy was acceptable and provided symptomatic relief to patients with COPD during exercise. These data will inform larger pilot studies and efficacy studies of fan therapy during exercise.

Conflict of interest statement

Conflict of interest: A. Long has nothing to disclose. Conflict of interest: M. Cartwright has nothing to disclose. Conflict of interest: C.C. Reilly has nothing to disclose.

Copyright ©The authors 2021.

Figures

FIGURE 1
FIGURE 1
Study design and flow of patient through the study protocol: a pilot single-centre randomised controlled crossover open (nonmasked) trial of hand-held fan therapy (HHFT) versus no HHFT during 6-min walk test (6MWT) in patients with COPD and modified Medical Research Council dyspnoea score ≥2.

References

    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management and Prevention of COPD. 2017. Available from:
    1. Lozano R, Naghavi M, Foreman K, et al. . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2012; 380: 2095–2128. doi:10.1016/S0140-6736(12)61728-0
    1. British Lung Foundation. Chronic Obstructive Pulmonary Disease (COPD) Statistics. 2020. .
    1. Jolley CJ, Moxham J. A physiological model of patient-reported breathlessness during daily activities in COPD. Eur Respir Rev 2009; 18: 66–79. doi:10.1183/09059180.00000809
    1. O'Donnell DE, James MD, Milne KM, et al. . The pathophysiology of dyspnea and exercise intolerance in chronic obstructive pulmonary disease. Clin Chest Med 2019; 40: 343–366. doi:10.1016/j.ccm.2019.02.007
    1. Seymour JM, Moore L, Jolley CJ, et al. . Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax 2010; 65: 423–428. doi:10.1136/thx.2009.124164
    1. Man WD-C, Soliman MGG, Gearing J, et al. . Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 168: 562–567. doi:10.1164/rccm.200302-162OC
    1. Swan F, Booth S. The role of airflow for the relief of chronic refractory breathlessness. Curr Opin Support Palliat Care 2015; 9: 206–211. doi:10.1097/SPC.0000000000000160
    1. Booth S, Galbraith S, Ryan R, et al. . The importance of the feasibility study: lessons from a study of the hand-held fan used to relieve dyspnea in people who are breathless at rest. Palliat Med 2016; 30: 504–509. doi:10.1177/0269216315607180
    1. Gysels MH, Higginson IJ. The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND. BMC Palliat Care 2011; 10; 15. doi:10.1186/1472-684X-10-15
    1. Hutchinson A, Pickering A, Williams P, et al. . Breathlessness and presentation to the emergency department: a survey and clinical record review. BMC Pulm Med 2017; 17: 53. doi:10.1186/s12890-017-0396-4
    1. Brighton LJ, Miller S, Farquhar M, et al. . Holistic services for people with advance disease and chronic breathlessness: a systematic review and meta-analysis. Thorax 2019; 74: 270–281. doi:10.1136/thoraxjnl-2018-211589.
    1. Smallwood N, Thompson M, Warrender-Sparkes M, et al. . Integrated respiratory and palliative care may improve outcomes in advanced lung disease. ERJ Open Res 2018; 4: 00102-2017. doi:10.1183/23120541.00102-2017
    1. Johnson MJ, Currow DC, Booth S. Prevalence and assessment of breathlessness in the clinical setting. Expert Rev Respir Med 2014; 8: 151–161. doi:10.1586/17476348.2014.879530
    1. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377–381. doi:10.1249/00005768-198205000-00012
    1. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg scale, and visual analog scale. COPD 2005; 2: 105–110. doi:10.1081/COPD-200050655
    1. Singh SJ, Puhan MA, Andrianopoulos V, et al. . An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1447–1478. doi:10.1183/09031936.00150414
    1. Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res 2017; 17: 88. doi:10.1186/s12913-017-2031-8
    1. Holland AE, Spruit MA, Troosters T, et al. . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1428–1446. doi:10.1183/09031936.00150314
    1. Li T, Yu T, Hawkins BS, et al. . Design, analysis, and reporting of crossover trials for inclusion in a meta-analysis. PLoS One 2015; 10: e0133023. doi:10.1371/journal.pone.0133023
    1. Marchetti N, Lammi MR, Travaline JM, et al. . Air current applied to the face improves exercise performance in patients with COPD. Lung 2015; 193: 725–731. doi:10.1007/s00408-015-9780-0
    1. Campbell M, Fitzpatrick R, Haines A, et al. . Framework for design and evaluation of complex interventions to improve health. BMJ 2000; 321: 694–696. doi:10.1136/bmj.321.7262.694.
    1. Craig P, Dieppe P, Macintyre S, et al. . Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008; 337: a1655. doi:10.1136/bmj.a1655
    1. Moore GF, Audrey S, Barker M, et al. . Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015; 350: h1258. doi:10.1136/bmj.h1258
    1. O'Cathain A, Croot L, Duncan E, et al. . Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open 2019; 9: e029954. doi:10.1136/bmjopen-2019-029954.
    1. Haynes B. Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ 1999; 319: 652–653. doi:10.1136/bmj.319.7211.652
    1. Say RE, Thomson R. The importance of patient preferences in treatment decisions – challenges for doctors. BMJ 2003; 327: 542–545. doi:10.1136/bmj.327.7414.542
    1. Sidani S, Braden CJ. Testing the acceptability and feasibility of interventions. In: Design, Evaluation, and Translation of Nursing Interventions. Chichester, John Wiley & Sons, 2011; pp. 163–196.
    1. Bausewein C, Booth S, Gysels M, et al. . Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care 2010; 9: 22. doi:10.1186/1472-684X-9-22
    1. Johnson MJ, Simpson MI, Currow DC, et al. . Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot. BMJ Open 2015; 5: e007535. doi:10.1136/bmjopen-2014-007535
    1. Pattinson KTS, Johnson MJ. Neuroimaging of central breathlessness mechanisms. Curr Opin Support Palliat Care 2014; 8: 225–233. doi:10.1097/SPC.0000000000000069
    1. von Leupoldt A, Sommer T, Kegat S, et al. . The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am J Respir Crit Care Med 2008; 177: 1026–1032. doi:10.1164/rccm.200712-1821OC
    1. Schwartzstein RM, Lahive K, Pope A, et al. . Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987; 136: 58–61. doi:10.1164/ajrccm/136.1.58
    1. Simon PM, Basner RC, Weinberger SE, et al. . Oral mucosal stimulation modulates intensity of breathlessness induced in normal subjects. Am Rev Respir Dis 1991; 144: 419–422. doi:10.1164/ajrccm/144.2.419
    1. Morélot-Panzini C. Fooling the brain to alleviate dyspnoea. Eur Respir J 2017; 50: 1701383. doi:10.1183/13993003.01383-2017
    1. Chin C, Booth S. Managing breathlessness: a palliative care approach. Postgrad Med J 2016; 92: 393–400. doi:10.1136/postgradmedj-2015-133578
    1. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167: 53–60. doi:10.1016/j.resp.2008.07.012
    1. Gysels M, Reilly CC, Jolley CJ, et al. . How does a new breathlessness support service affect patients? Eur Respir J 2015; 46: 1515–1518. doi:10.1183/13993003.00751-2015
    1. Oxberry SG, Bland JM, Clark AL, et al. . Minimally clinically important difference in chronic breathlessness: every little helps. Am Heart J 2012; 164: 229–235. doi:10.1016/j.ahj.2012.05.003
    1. Elbourne DR, Altman DG, Higgins JPT, et al. . Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002; 31: 140–149. doi:10.1093/ije/31.1.140
    1. Higginson IJ, Bausewein C, Reilly CC, et al. . An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2014; 2: 979–987. doi:10.1016/S2213-2600(14)70226-7
    1. Mundy J, Stansfeld J, Orrell M, et al. . Reasons for nonparticipation in the Valuing Active Life in Dementia randomised controlled trial of a dyadic occupational therapy intervention: an interview study. SAGE Open Med 2020; 8: 2050312120958926. doi:10.1177/2050312120958926
    1. Grabowski T, Gad SC, Jaroszewki JJ, et al. . Deterministic chaos and wash-out determination in crossover trials. Int J Pharmacokinet 2016; 1: 43–53. doi:10.4155/ipk.16.1
    1. Galbraith S, Fagan P, Perkins P, et al. . Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010; 39: 831–838. doi:10.1016/j.jpainsymman.2009.09.024

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다